Literature DB >> 16301571

Neuroanatomical phenotyping in the mouse: the dopaminergic system.

C J Zeiss1.   

Abstract

Voluntary movement in animals is modulated by a number of subcortical systems. One of these resides in the basal nuclei and their associated projections and utilizes dopamine as a neurotransmitter. Apart from regulating movement, the dopaminergic axis is also involved in the control of goal-oriented behavior, cognition, and mood. Disorders of this system result in common human neurologic disorders such as Parkinson's and Huntington's diseases, as well contributing to a host of behavioral conditions, such as schizophrenia, attention deficit hyperactivity disorder, and addiction. Many individual mouse models of human dopaminergic dysfunction have been described in varying degrees of detail. However, when evaluating this region of the brain, the veterinary pathologist is confronted by a paucity of information summarizing the comparative aspects of the anatomy, physiology, and pathology of the central dopaminergic system. In this review, a systematic approach to anatomic phenotyping of the central dopaminergic system in the mouse is described and illustrated using tyrosine hydroxylase immunohistochemistry. Differences between murine neuroanatomy and comparable regions of the nonhuman primate brain are highlighted. Although the mouse is the focus of this review, conditions in domestic animals characterized by lesions within the basal nuclei and its projections are also briefly described. Murine behavioral and motor tests that accompany abnormalities of specific anatomic regions of the dopaminergic axis are summarized. Finally, we review mouse models of Parkinson's and Huntington's diseases, as well as those genetically altered mice that elucidate aspects of dopamine metabolism and receptor function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301571     DOI: 10.1354/vp.42-6-753

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  15 in total

1.  Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.

Authors:  Alba Tristán-Noguero; Héctor Díez; Cristina Jou; Mercè Pineda; Aida Ormazábal; Aurora Sánchez; Rafael Artuch; Àngels Garcia-Cazorla
Journal:  Metab Brain Dis       Date:  2015-12-21       Impact factor: 3.584

2.  Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

Authors:  T D Irons; P E Kelly; D L Hunter; R C Macphail; S Padilla
Journal:  Pharmacol Biochem Behav       Date:  2012-12-28       Impact factor: 3.533

3.  Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Min-Hsiu Hu; Wen-Shin Liu; Pin-Wen Chen; Wei-Hua Wang; Kai-Yuan Tzen; Barry J Byrne; Wuh-Liang Hwu
Journal:  Hum Gene Ther       Date:  2014-01-07       Impact factor: 5.695

Review 4.  Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

Authors:  Silvia Giatti; Silvia Diviccaro; Giancarlo Panzica; Roberto Cosimo Melcangi
Journal:  Endocrine       Date:  2018-04-19       Impact factor: 3.633

Review 5.  HIV, Tat and dopamine transmission.

Authors:  Peter J Gaskill; Douglas R Miller; Joyonna Gamble-George; Hideaki Yano; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2017-04-27       Impact factor: 5.996

Review 6.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

7.  Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage.

Authors:  K L Grinnell; J R Bickenbach
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

8.  Characterization of neuropathology in the HIV-1 transgenic rat at different ages.

Authors:  William C Reid; Wael G Ibrahim; Saejeong J Kim; Frank Denaro; Rafael Casas; Dianne E Lee; Dragan Maric; Dima A Hammoud
Journal:  J Neuroimmunol       Date:  2016-02-03       Impact factor: 3.478

9.  Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.

Authors:  Kevin N Hascup; Xiaodong Bao; Erin R Hascup; Dongwei Hui; Wenhao Xu; Francois Pomerleau; Peter Huettl; Mary L Michaelis; Elias K Michaelis; Greg A Gerhardt
Journal:  ASN Neuro       Date:  2011-04-21       Impact factor: 4.146

10.  A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.

Authors:  Diana M Hendrickx; Pierre Garcia; Amer Ashrafi; Alessia Sciortino; Kristopher J Schmit; Heike Kollmus; Nathalie Nicot; Tony Kaoma; Laurent Vallar; Manuel Buttini; Enrico Glaab
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.